Characterization and drug sensitivity of a novel human ovarian clear cell carcinoma cell line genomically and phenotypically similar to the original tumor
Abstract NUCOLL43 is a novel ovarian clear cell carcinoma (O‐CCC) cell line that arose from a primary culture of a patient's malignant ascites. The cells grow reliably in cell culture with a doubling time of approx. 45 hours and form colonies at high efficiency. They have a very high degree of...
Saved in:
| Main Authors: | Miriam Franklin, Lucy Gentles, Elizabeth Matheson, Nick Bown, Paul Cross, Angela Ralte, Connor Gilkes‐Immeson, Alice Bradbury, Maryam Zanjirband, John Lunec, Yvette Drew, Rachel O'Donnell, Nicola J. Curtin |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2018-09-01
|
| Series: | Cancer Medicine |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/cam4.1724 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Vinblastine plus NVP-BEZ235 inducing apoptosis of human renal tumor cells
by: QIN Dan, et al.
Published: (2018-01-01) -
Autophagic degradation of CDK4 is responsible for G0/G1 cell cycle arrest in NVP-BEZ235-treated neuroblastoma
by: Zhen Liu, et al.
Published: (2024-12-01) -
Dual PI3K/mTOR inhibitor NVP-BEZ235 induces cell cycle arrest via autophagy mediated protein degradation of RPL19 in nephroblastoma cell
by: Yan Gao, et al.
Published: (2025-07-01) -
Nanoemulsification of PTX and BEZ235 inhibits colon cancer growth
by: Xingyao Zhu, et al.
Published: (2025-05-01) -
Clear cell variant of oral squamous cell carcinoma
by: Mamata Kamat, et al.
Published: (2025-01-01)